What are the pharmacy supervision changes?
The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 followed draft legislation published by the Department of Health and Social Care in July 2025, itself following consultation upon proposals to amend the Medicines Act 1968 and the Human Medicines Regulations 2012. The Order was approved by Parliament and the Privy Council, and the GPhC confirmed the commencement arrangements in a statement published on 12 December 2025.
It takes effect in two phases separated by a one-year transition period, which the Order provides in order to permit the GPhC and the professional leadership bodies to develop and publish supporting standards and guidance. The first phase commenced on 7 January 2026 and has therefore been operating for some months. The second commences on 10 December 2026, which at the time of writing is approximately four and a half months distant, and remains conditional upon the publication of standards which do not yet exist.
The stated purpose, in the regulator's language, is to enable pharmacists to deliver more patient-facing clinical services whilst enabling pharmacy technicians to maximise their contribution through effective use of their skills and expertise. Whether the reforms achieve that depends considerably upon arrangements which have not been settled, which is the subject of the later sections of this guide.
Can staff hand out prescriptions when the pharmacist is absent?
Pharmacists became able to authorise the handing out of checked and bagged prescriptions when the pharmacist is absent or treated as absent. That is the whole of the first phase, and its narrowness relative to the surrounding commentary warrants stating plainly.
One point of precision is worth recording, since much of the coverage obscured it. The GPhC's published position is that a pharmacist may authorise any member of pharmacy staff to hand out checked and bagged prescriptions in the pharmacist's absence, rather than pharmacy technicians alone. Reporting at the time framed the change in terms of pharmacy technicians, which is accurate as a description of who will ordinarily be authorised and inaccurate as a description of what the legislation permits.
Two further matters settle the operational position. The Royal College of Pharmacy published guidance addressing authorisation by a pharmacist in respect of checked and bagged prescriptions, which is the appropriate reference for how the arrangement should be operated. And Community Pharmacy England confirmed in December 2025 that the change is available to NHS community pharmacies without any amendment to the Terms of Service under the 2013 Regulations, which removed a question a number of contractors had raised.
The practical effect within a community pharmacy is modest and real. A patient collecting a prescription which a pharmacist has already checked and bagged need no longer be turned away because the pharmacist has stepped out, which addresses a recurring frustration for patients and a recurring inefficiency for pharmacies, without altering who performed the clinical check or when.
Can pharmacy technicians dispense without a pharmacist from December 2026?
The second phase is materially more substantial and comprises two provisions.
Pharmacists will be able to authorise a pharmacy technician to undertake or supervise the preparation, assembly, dispensing and sale and supply of medicines which would otherwise require performance by, or supervision of, a pharmacist. And pharmacy technicians will be able to take primary responsibility for the preparation and assembly of medicinal products in hospital aseptic facilities, under Regulation 4A of the Human Medicines Regulations 2012.
Both provisions are conditional. The GPhC, the Pharmaceutical Society of Northern Ireland and the professional leadership bodies must publish supporting professional standards and guidance before they take effect, which is the purpose the transition period serves and which introduces the timing question examined below.
The change of legal architecture warrants noting for its own sake. The existing framework requires certain activities to be performed by a pharmacist or under a pharmacist's supervision, with supervision understood as a contemporaneous professional relationship. The new provision permits a pharmacist to authorise a pharmacy technician to undertake or supervise those activities, which separates the activity from the pharmacist's immediate presence and relocates the pharmacist's contribution into the authorisation decision. That is a different mechanism rather than a relaxed version of the existing one, and it is why the accompanying governance arrangements carry so much weight.
Do you still need a responsible pharmacist?
These reforms are frequently discussed as though they permitted pharmacies to operate without pharmacists, and they do not. The GPhC's published position addresses four matters directly. The legislation does not alter the requirement for a Responsible Pharmacist to be on duty at each registered pharmacy. It does not permit a pharmacy technician to perform the role of Responsible Pharmacist. It is not intended to allow the Responsible Pharmacist to be absent from the pharmacy for longer than two hours. And it does not permit the Responsible Pharmacist to supervise pharmacy staff remotely. Those four propositions together dispose of most of what the reforms are popularly supposed to have done. What has changed is what may be delegated, by authorisation, whilst a Responsible Pharmacist remains in post and present within the ordinary limits. What has not changed is the existence of that post, its occupancy by a pharmacist, or the expectation that the pharmacist is generally there.
An operator planning around the reforms should therefore treat them as altering the division of labour within a pharmacy rather than the staffing model of one. A business case constructed upon reduced pharmacist hours misreads both the legislation and the regulator's stated position, and would in any event be constructed upon standards which are not yet published.
When will the GPhC publish the new standards?
The second phase depends upon supporting standards and rules, and their development has taken longer than the transition period comfortably accommodates.
The GPhC Council agreed on 11 December 2025 to consult upon proposed standards for Superintendent Pharmacists and Responsible Pharmacists, together with Rules for Responsible Pharmacists, intended to clarify and strengthen the organisational governance arrangements for registered pharmacies. The consultation ran from 17 December 2025 to 25 March 2026 and attracted 411 responses, comprising 404 through the survey and seven submitted more generally by individuals and organisations.
Having considered that feedback, the regulator indicated that certain matters raised require additional consideration and clarification before the standards and rules can be finalised, and that some points may be more appropriately addressed within supporting guidance than within standards which are intended to be high level and outcome focused. A final draft is to be brought to a Council meeting scheduled for 5 October 2026, and the standards and rules must be published before the second phase commences on 10 December 2026.
The arithmetic of that timetable warrants attention from anyone planning implementation. Standards approved in early October and published thereafter leave a period measured in weeks, rather than months, between publication and commencement, during which pharmacies must read them, revise procedures, train staff and settle authorisation arrangements. A pharmacy which intends to use the second phase from December should therefore prepare the elements which do not depend upon the standards now, so that the remaining work is adaptation rather than construction.
How does a pharmacist authorise a pharmacy technician?
The legislation operates through authorisation by a pharmacist, and the word carries more weight than its brevity suggests.
Authorisation implies a decision concerning a particular individual and a particular scope, made by a pharmacist who is accountable for having made it, rather than a permission attaching automatically to a job title. That construction raises questions which the forthcoming standards and rules are expected to address, comprising how an authorisation is recorded, how its scope is expressed, how competence is assured before it is given, how it is reviewed, and how it is withdrawn where circumstances change.
Until those questions are answered, a pharmacy can nonetheless settle the matters which are plainly within its own control. Who would be authorised, and upon what evidence of competence. What the scope would be, expressed by activity rather than by generality. Who within the organisation may authorise, and whether that decision sits with the Responsible Pharmacist on duty, the Superintendent, or both in different respects. And how the arrangement would be recorded such that an inspector reconstructing a supply could establish who was authorised to do what, and when.
Those four questions constitute the substance of implementation, and none of them requires the standards to be published before it can be considered.
What are the new superintendent pharmacist standards?
The reforms are accompanied by a strengthening of the governance framework rather than a relaxation of it, which is a pattern this library has observed in other recent changes.
The GPhC has described its work as introducing new regulatory standards for Superintendent Pharmacists and Responsible Pharmacists, together with Rules for Responsible Pharmacists, specifically to clarify and strengthen organisational governance arrangements for registered pharmacies. That is a considerable development in its own right, since the superintendent role has historically been defined more by statute and custom than by a dedicated set of regulatory standards, and a pharmacy reading only the supervision provisions will encounter the governance requirements as a surprise.
The practical consequence resembles that identified in the hub and spoke thematic review, in which the regulator's attention concentrated not upon the permitted activity but upon whether governance kept pace with it. Pharmacies intending to use the second phase should expect the same question, and the standards being developed indicate in advance what form it will take.
Why do some pharmacists oppose the supervision changes?
The reforms are supported and contested along lines worth understanding, since both positions bear upon how a pharmacy should implement them.
Community Pharmacy England's director of legal welcomed the changes as improving the extent of care patients receive, reducing delays in accessing medicines and improving access to services, characterising them as a step toward bringing care closer to communities consistent with the ten-year health plan.
The Pharmacists' Defence Association has supported modernisation whilst maintaining that role clarity and professional identity are non-negotiable, and has argued a specific point which merits attention. Because preparation, assembly, sale and supply may now be separated from the clinical check, and because the legislation creates additional requirements around pharmacy technician authorisation, the association contends that the single set of standards hitherto applied to both pharmacists and pharmacy technicians should be replaced by two separate and distinct sets, referring to the recommendations of the Leng Review in support.
That argument identifies something real irrespective of where a reader lands upon it. Where two professions may perform overlapping activities under different accountabilities, the standards distinguishing them do practical work, and a pharmacy implementing the second phase will encounter the same question internally when it decides what an authorised technician does, what remains with the pharmacist, and how each is held to account.
A related development supports the point. The GPhC has raised the minimum level of study within its new training standards for pharmacy technicians, attributing the change to the widening scope of the role, including the introduction of patient group directions permitting technicians to administer and supply certain medicines, and the forthcoming legislation enabling them to take responsibility for dispensing and supplying without pharmacist supervision.
How should a pharmacy prepare for 10 December 2026?
Five matters may be addressed now, before the standards are published, and doing so converts the post-publication period from construction into adaptation.
Establish the current position honestly. Which activities presently require pharmacist performance or supervision within this pharmacy, and where the constraint actually binds. A pharmacy which has not identified that will delegate the wrong things.
Assess the technician workforce. Registration status, competence, experience and the training which would be required, recognising that the regulator has raised the minimum level of study for future entrants and that existing team members will vary considerably.
Draft the authorisation architecture. Who authorises, on what evidence, in what scope, recorded how, reviewed when, withdrawn by whom. Expect to revise it once the standards appear, and expect that revising a draft is considerably faster than producing one.
Identify the procedures which will require amendment. The dispensing procedures, the responsible pharmacist procedures and the training records will each be affected, and our SOP guide addresses the discipline which keeps that work manageable rather than becoming a rewrite.
Decide whether to use the second phase at all. It is a permission rather than a requirement, and a pharmacy whose constraint is demand rather than pharmacist availability may gain little whilst acquiring governance obligations. That decision is legitimate, should be taken deliberately, and should be recorded.
Do the supervision changes apply in Scotland, Wales and Northern Ireland?
The Order is Great Britain legislation, whilst the professional standards which condition the second phase are being developed by the GPhC for Great Britain and by the Pharmaceutical Society of Northern Ireland for Northern Ireland. Operators working across those jurisdictions should expect the professional framework, and potentially its timing, to differ even where the underlying legislative change corresponds, and should rely upon the guidance issued by the regulator for the jurisdiction in which the pharmacy is registered.
Key takeaways
- The 2025 Order takes effect in two phases, with the first operating since 7 January 2026 and the second commencing 10 December 2026 following a one-year transition period.
- The first phase permits a pharmacist to authorise the handing out of checked and bagged prescriptions during absence, and the GPhC's position is that any member of pharmacy staff may be authorised rather than pharmacy technicians alone.
- The second phase permits authorisation of a pharmacy technician to undertake or supervise preparation, assembly, dispensing and sale and supply, together with primary responsibility for preparation and assembly in hospital aseptic facilities.
- The Responsible Pharmacist requirement is unchanged, a technician may not perform that role, absence beyond two hours is not intended, and remote supervision is not permitted.
- The supporting standards remain unpublished, with 411 consultation responses received, a final draft due at Council on 5 October 2026 and publication required before 10 December, which leaves weeks rather than months for implementation.
- Authorisation implies a decision about an individual and a scope rather than a permission attaching to a job title, and four questions concerning who, what, recorded how and reviewed when may be settled before the standards appear.
- The reforms arrive alongside strengthened governance standards for Superintendent and Responsible Pharmacists, and the second phase is a permission rather than a requirement which a pharmacy may decline deliberately.
FAQs
Who was authorised, to do what.
Authorisation is a records question before it is a staffing one, since an inspector reconstructing a supply will ask who was authorised to do what, by whom, and when. Dataforge PMR attributes each step of a dispensing journey to the person who performed it, which is the foundation the December arrangements will be built upon.
See Dataforge PMR